Language/Country
Sök search
 Skriv ut sida | JJnordic > Terapiområde > Fetma > Referenser
img
Fråga Johnson & Johnson

Jag accepterar integritetspolicyn
Referenser 

1 WHO – http://www.who.int/topics/obesity/en/
2 Kushner RF. Roadmaps for clinical practice: Case Studies in Disease Prevention and Health Promotion – Assessment and Management of Adult Obesity: A Primer for Physicians (Booklet 1: Introduction and Clinical Considerations).   Chicago, IL. American Medical Association 2003.
3 IASO press release, March 2003 http://www.iotf.org/media/iotfmar17.pdf
4 http://www.obesity-online.com/ifso/ifso-selection.htm
5 Fitch K, Pyenson B, Abbs S et al. Milliman Research Report. Obesity: A big problem   getting bigger. March 2004.
6 NICE “Guidance on the use of surgery to aid weight reduction for people with morbid obesity”, Technology Appraisal   Guidance n°46, july 2002.
7 Rationale for the Surgical Treatment of Morbid Obesity. [Online] 8 April 1998. www.asbs.org/html/ration.html.
8 Buchwald H et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;   292(14):1724-37.
9 American College of Surgeons. Recommendations for Facilities Performing Bariatric Surgery. Bulletin of American College   of Surgeons 2000; 85(9):20-3.
10 Sjöström L et al. Effects of bariatric surgery on mortality in Swedish obese subjects.   N Engl J Med 2007; 357(8):741-52.
11 Kaplan L. Body weight regulation and obesity. J Gastrointest Surg 2003; 7(4):443-51.
12 Sjöström L et al. Lifestyle, diabetes, and cardiovascular risk factors in 10 years after bariatric surgery. N Engl J Med   2004; 351(26):2683-93.
13 Presutti R, Gorman R, Swain J. Concise Review for Clinicians. Primary care perspective on bariatric surgery. Mayo Clin   Proc 2004; 79(9):1158-66.
14 Müller BP, Holzinger F, Leepin H, Klaiber C. Laparoscopic cholecystectomy: Quality of care and benchmarking. Results of a single-institution specialized in laparoscopy compared with those of a nationwide study in Switzerland. Surg Endosc   2003; 17(2):300-5.
15 Chevallier JM, Daoud F, Szwarcensztein K. Une évaluation médico-économique de l’obésité morbide par anneau gastrique ajustable suédois (SAGB). (Medicoeconomic evaluation of the treatment of morbid obesity by Swedish Adjustable Gastric   Banding (SAGB).) Ann Chir 2006; 131(1):12-21.
16 Steffen R et al. Laparoscopic Swedish adjustable gastric banding: a five-year prospective study.   Obes Surg 2003; 13(3):404-11.
17 Chapman AE et al. Laparoscopic adjustable gastric banding in the treatment of obesity: A systematic literature review.   Surgery 2004; 135:326-51.
18 Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y 500 patients: technique and results, with 3–60 month   follow-up. Obes Surg 2000; 10(3):233-9.
19 Pories WJ et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset   diabetes mellitus. Ann Surg 1995; 222(3):339-52.
20 Sekhar N et al. A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period.   Surg Endosc 2007; 21(4):665-8.
21 Baltasar A et al. Duodenal switch: an effective therapy for morbid obesity – intermediate results.   Obes Surg 2001; 11(1): 54-8.
22 Papaioannou A et al. Effects of weight loss on QT interval in morbidly obese patients.   Obes Surg 2003; 13(6):869-73.

 

Johnson & Johnson AB • Staffans väg 2 • 191 84 Sollentuna • Tel. 08-626 22 00 • E-post: jjnordic@jnjse.jnj.com

Denna webbplats är upprättad av Johnson & Johnson AB, som är helt ansvarig för dess innehåll. Sidan är avsedd för sjukvårdspersonal bosatta i Sverige.
© Johnson & Johnson AB 2009 - Senast uppdaterad: 2008-12-02 23:26